BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Technologies, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that it will participate in the upcoming Biotech Showcase™ 2021, being delivered digitally January 11 ‒ 15, 2021. Biotech Showcase is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities.
Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Technologies, and Paul Estrem, Executive Vice President and Chief Financial Officer, will provide an update on NorthStar and its progress in advancing U.S. radioisotope production. They will conduct meetings with institutional investors in conjunction with the event. Meetings can be arranged through the Biotech Showcase 2020 website or by contacting NorthStar Investor Relations.
“We are excited to share information about NorthStar’s success in advancing our commercialized product and expansion initiatives with the investor community at Biotech Showcase 2021,” said Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Technologies. “NorthStar continues to further deploy its innovative technology and development expertise to meet growing demands for medical radioisotopes. In our presentation and meetings, we will provide details on our portfolio of game-changing therapeutic and diagnostic products that are in development, and speak to the ways in which we believe that NorthStar is poised for continued rapid growth and industry leadership.”
About Biotech Showcase
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives. Now in its 13th consecutive year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings using the industry’s gold-standard platform, partneringOne®. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a combined history of over 50 years in producing high-quality programs that support the biotechnology and broader life sciences industry.
About NorthStar Medical Technologies, LLC (NorthStar)
NorthStar Medical Radioisotopes is a global innovator in development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals. Founded in 2006 and based in Beloit, Wis., NorthStar Medical Technologies is the parent organization of several wholly-owned subsidiaries, including NorthStar Medical Radioisotopes, LLC. NorthStar Medical Radioisotopes is a nuclear medicine technology company providing the United States with reliable and environmentally friendly radioisotope supply solutions to meet the needs of patients and to advance clinical research. Its commercialized, U.S.-based radioisotope production is available nationwide to help meet patients’ needs for important diagnostic imaging radiopharmaceuticals, and is expanding for the future. NorthStar’s portfolio encompasses commercial development processes for therapeutic radiopharmaceutical production, strategic collaborations researching the use of therapeutic radiopharmaceuticals for the treatment of infectious disease such as COVID-19, and research into a novel thrombin imaging agent for potential use in helping to identify specific forms of cardiovascular disease. NorthStar’s proprietary and patented technologies include domestic production methods, patented separation chemistry systems, patented sterilization systems and a technology platform that potentially allows expanded product offerings to provide solutions in both the diagnostic and therapeutic markets. For more information, visit: www.northstarnm.com